1 / 10

Writing the Discussion: A Step-By-Step Guide for Researchers

This guide provides step-by-step instructions on writing the discussion section of a research paper, with a focus on identifying key issues, refining ideas, and creating a polished text. It includes tips, outline points, and suggestions for clinicians, public health professionals, and policy makers.

ccrews
Download Presentation

Writing the Discussion: A Step-By-Step Guide for Researchers

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Writing the Discussion (Simon Capewell, Day 2) A. start with the abstract, refine that. • This helps identify key issues around WHY, HOW, WHAT found, WHAT does it mean

  2. Writing the Discussion (Simon Capewell, Day 2) A. start with the abstract. Refine that. • This helps identify key issues around: • WHY, HOW, WHAT found, WHAT does it mean B. Draft outline points for each section in Discussion C: Create bullet points for each paragraph D: Turn bullet points into text E: Refine & polish text. Most important sentences: FIRST, and LAST

  3. Writing the Discussion (Simon Capewell, Day 2) A. start with the abstract, refine that. • This helps identify key issues around WHY, HOW, WHAT found, WHAT does it mean B. Draft outline points for each section in Discussion: • Para 1: main message(s) • Para 2: Comparison with other studies • Para 3: Expand on key messages (optional) • Para 4: Strengths & Weaknesses (limitations) • Para 5: Implications for: clinicians; public health professionals; policy makers.

  4. Writing the Discussion (Simon Capewell, Day 2) A. start with the abstract. Refine that. • This helps identify key issues around: • WHY, HOW, WHAT found, WHAT does it mean B. Draft outline points for each section in Discussion C: Create bullet points for each paragraph D: Turn bullet points into text E: Refine & polish. Most important sentences: FIRST, and LAST

  5. RESCAP-MED:University of Liverpool

  6. United Kingdom • Pop: 62 million • World 7th largest economy (GDP & purchasing power parity). • CVD remains biggest killer about 190,000 deaths per year estimated cost $45 billion per year • 2012: • Queen Diamond Jubilee • Summer Olympics • Please visit!

  7. University of Liverpool Department of Public Health & Policy • Department of Public Health and Policy is home to many disciplines • Research themes: • Inequalities-Social context and consequences of ill-health • Clinical effectiveness • Health impact assessment • Undergraduate and graduate medical education: • Successful MPH program (on campus, & on-line) • PhD programme

  8. Our Team • Prof Simon Capewell: Chair of Clinical Epidemiology • Dr Martin O’Flaherty Lecturer in Epidemiology • Our Research Interests: • Examining what drives cardiovascular disease (CVD) mortality rates in a range of high, middle & low income countries • The development of effective and cost-saving cardiovascular prevention strategies in the UK and beyond: building on empirical evidence, policy analyses, and quantitative modelling • How best to help policy makers develop effective non-communicable disease prevention strategies in low, middle & high- income countries

  9. RESCAP MED and Liverpool • Main Role: • Fellowships program (host) • Previous successful and productive experience in introducing young researchers to public health policy decision making and modelling. • Co-participants in Marie Curie project led by Kath Bennett • Collaboration with researchers in Portugal, Denmark, Holland, Spain • MedCHAMPS experience helping develop public health & modelling skills within four national teams: Developed & implemented CHD, diabetes & Stroke models(Syria, Palestine Tunisia & Turkey) Strong support for consolidating & expanding the understanding of Public Health Policy Modelling in the region, as a tool that facilitates dialogue with policy stakeholders

More Related